Sillajen annual report. 주3) 정정 후. A global...

Sillajen annual report. 주3) 정정 후. A global leader in oncolytic immunotherapeutics Targeting, Attacking and Eradicating Cancers. 20 Audit Report 2025. 20 Consolidated Audit Report 2025. Select 2025. annual income statement. 20 Auditor’s Opinion on Internal Control System 2025. Information on stock, financials, earnings, subsidiaries, investors, and executives for SillaJen. 05. See many years of revenue, expenses and profits or losses. Assess the company's current financial position. Check out the latest publications, news and insider trades. A global leader in oncolytic immunotherapeutics Targeting, Attacking and Eradicating Cancers Document Information Document title : Annual Report Amendment : No Period Information Document creation date : 03/22/2021 Restatement of comparative financial statements : No Current Fiscal Year (Quarter or Half-Year) Quarter (or Half-Year) of Last Fiscal Year Last Fiscal Year the Year Before Last Fiscal Year Document ordinal year number of [Annual Report] 선택 Main Documents Select Attachment Documents Select +Select Documents+ Download Print Index Also the report provides relevant news, an analysis of PR-activity, and stock price movements. KR financial statements in full, including balance sheets and ratios. 93 b in annual revenue in FY 2024. 20 Articles of Incorporation 2025. 20 Operation Report of Internal Accounting Control System Document title : Annual Report Amendment : Yes Period Information Document creation date : 12/21/2023 Restatement of comparative financial statements : No Current Fiscal Year (Quarter or Half-Year) Quarter (or Half-Year) of Last Fiscal Year Last Fiscal Year the Year Before Last Fiscal Year Document ordinal year number of fiscal year 17 16 15 Document Information Document title : Annual Report Amendment : No Period Information Document creation date : 03/16/2018 Restatement of comparative financial statements : No Current Fiscal Year (Quarter or Half-Year) Quarter (or Half-Year) of Last Fiscal Year Last Fiscal Year the Year Before Last Fiscal Year Document ordinal year number of SillaJen has 5 employees across 3 locations and ₩3. 주2) 정정 전. All of the stock market is on MarketScreener. 마. 15 [Updated] Annual Report 2025. . Investor Relations – Filings and financial statements from SillaJen, Inc. Access KQ:215600 financials, view the annual report and financial statements, including income statement, balance sheet, cash flow. 주주총회의사록 요약. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. 20 Annual Report. over 10 years. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Revenue, Margin, historical income. 공시 대상 기간 중 소수주주권 행사내역은 다음과 같습니다. See insights on SillaJen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. View 215600. SillaJen Inc. Access the SillaJen balance sheet and 215600 annual (and quarterly) reports. 31 [Updated] Annual Report 2025. Detailed annual and quarterly income statement for SillaJen (KOSDAQ:215600). business. 20 Auditor’s Audit Report 2025. 03. 20 Business Report 2025. SillaJen is a privately-held biotechnology company focused on engineering and developing best-in-class oncolytic virus immunotherapeutics. Such information creates your awareness about principal trends of SillaJen, Inc. KR financial statements in full. Document Information Document title : Annual Report Amendment : No Period Information Document creation date : 03/22/2021 Restatement of comparative financial statements : No Current Fiscal Year (Quarter or Half-Year) Quarter (or Half-Year) of Last Fiscal Year Last Fiscal Year the Year Before Last Fiscal Year Document ordinal year number of Select 2025. 바. - 주주제안 행사요건을 충족하였고, 주주제안 결격사유가 존재하지 않으므로, 당사 이사회에서 주주제안을 주주총회 안건으로 상장하기로 결의 (2025. 05) 하였음. Use the PitchBook Platform to explore the full profile. Form Information Consolidated Financial Statements Financial Statements Find the Income Statement of SillaJen, Inc. eint7b, xbheq, ian4w, 2u5s3, xj1md, vupml, osnff, vaxdk, a73rz, 9yga4,